PreprintCited by 837SARS-CoV-2 detection and testingCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research

Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis and monitoring the viral shedding of 2019-nCoV infections.

Open access
Yang, Yang, Yang, Minghui, Shen, Chenguang, Wang, Fuxiang, Yuan, Jing, Li, Jinxiu, Zhang, Mingxia, Wang, Zhaoqin +14 more·2020·The Innovation

Abstract

Background: The outbreak of novel coronavirus pneumonia (NCP) caused by 2019-nCoV spread rapidly, and elucidating the diagnostic accuracy of different respiratory specimens is crucial for the control and treatment of this disease. Methods: Respiratory samples including nasal swabs, throat swabs, sputum and bronchoalveolar lavage fluid (BALF) were collected from Guangdong CDC confirmed NCP patients, and viral RNAs were detected using a CFDA approved detection kit. Results were analyzed in combination with sample collection date and clinical information. Findings: Except for BALF, the sputum possessed the highest positive rate (74.4%∼88.9%), followed by nasal swabs (53.6%∼73.3%) for both severe and mild cases during the first 14 days after illness onset (d.a.o). For samples collected ≥ 15 d.a.o, sputum and nasal swabs still possessed a high positive rate ranging from 42.9%∼61.1%. The positive rate of throat swabs collected ≥ 8 d.a.o was low, especially in samples from mild cases. Viral RNAs could be detected in all the lower respiratory tract of severe cases, but not the mild cases. CT scan of cases 02, 07 and 13 showed typical viral pneumonia with ground-glass opacity, while no viral RNAs were detected in first three or all the upper respiratory samples. Interpretation: Sputum is most accurate for laboratory diagnosis of NCP, followed by nasal swabs. Detection of viral RNAs in BLAF is necessary for diagnosis and monitoring of viruses in severe cases. CT scan could serve as an important make up for the diagnosis of NCP. Funding: National Science and Technology Major Project, Sanming Project of Medicine and China Postdoctoral Science Foundation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/2020.02.11.20021493

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • SARS-CoV-2 can be detected from different body fluids and the rate of positive test results vary depending on the sample size, days after illness onset, and severity of illness.

    “SARS-CoV-2 can be detected from different body fluids and the rate of positive test results vary depending on the sample size, days after illness onset, and severity of illness.”

    From Oral Microbiome and SARS-CoV-2: Beware of Lung Co-infection (2020) · cites this paper as Yang et al., 2020

  • Sputum appeared to be a good clinical sample with a high positive rate (74.4∼88.9%), followed by nasal swabs (53.6∼73.3%) and throat swabs (50∼61.3%).

    “Sputum appeared to be a good clinical sample with a high positive rate (74.4∼88.9%), followed by nasal swabs (53.6∼73.3%) and throat swabs (50∼ 61.3%).”

    From Oral Microbiome and SARS-CoV-2: Beware of Lung Co-infection (2020) · cites this paper as Yang et al., 2020

  • In a study on 213 confirmed COVID-19 patients, viral RNA could be detected in all BALF samples of severe cases, but not from mild cases.

    “According to a study on 213 confirmed COVID-19 patients, viral RNA could be detected in all BALF samples of severe cases, but not from mild cases.”

    From Oral Microbiome and SARS-CoV-2: Beware of Lung Co-infection (2020) · cites this paper as Yang et al., 2020

  • When the onset time was greater than 14 days, the positive rate of BALF, sputum, and nasal swabs showed similar results, and were still much higher than throat swabs.

    “When the onset time was greater than 14 days, the positive rate of BALF, sputum, and nasal swabs showed similar results, and were still much higher than throat swabs (Yang et al., 2020).”

    From Oral Microbiome and SARS-CoV-2: Beware of Lung Co-infection (2020) · cites this paper as Yang et al., 2020

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 36 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Yang, Y., Yang, M., Shen, C., Wang, F., Yuan, J., Li, J., Zhang, M., Wang, Z., Xing, L., Wei, J., Peng, L., Wong, G., Zheng, H., Wu, W., Liao, M., Feng, K., Li, J., Yang, Q., Zhao, J., Zhang, Z., Liu, L., & Liu, Y.
Affiliations
  • Southern University of Science and Technology (CN)
  • Chinese Academy of Sciences (CN)
Corresponding author
Zhang, Zheng
Venue
The Innovation
Publisher
openRxiv
Published
2020-02-12
Volume
1
Issue
3
Pages
100061-100061
ISSN
2666-6758 (ISSN-L)
OpenAlex
W3107529852
Cited by
836
References
36
Citations by year
2026: 2 · 2025: 18 · 2024: 23 · 2023: 62 · 2022: 114 · 2021: 246 · 2020: 370
FWCI
25.98
Type
journal article
Language
en
Open access
Licence
cc-by-nc-nd
Locations
  • The Innovation (publishedVersion, cc-by-nc-nd)
  • medRxiv (acceptedVersion)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Ministry of Science and Technology of the People's Republic of China (2020YFC0846300)
  • China Postdoctoral Science Foundation (2019M660836, 2019T120147)
  • National Science and Technology Major Project (2017ZX10204401, 2018ZX10711-001, 2017ZX10103011)
  • Sanming Project of Medicine in Shenzhen (SZSM201512005, SZSM201412003)
  • National Major Science and Technology Projects of China (2018ZX10711001, 2017ZX10103011)
Topics
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 detection and testing
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Keywords
SARS-CoV-2, COVID-19 pandemic, viral shedding, sputum, nasal swabs, bronchoalveolar lavage fluid, viral RNA detection, diagnostic accuracy, disease severity, ground-glass opacities

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review